In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Timothy Betts
Speaker
Timothy Betts
Timothy Betts Timothy Betts

Oxford University Hospitals NHS Trust, Oxford (United Kingdom of Great Britain & Northern Ireland)

Specialities : Arrhythmias-General , Atrial Fibrillation, Device Therapy

Consultant Cardiologist and Electrophysiologist and University Research Lecturer. Clinical and Research Lead for Cardiac Rhythm Management. Performs catheter ablation (including complex AF and VT), complex devices (including CRT and LV endocardial pacing), lead extraction and percutaneous left atrial appendage occlusion. Graduated from Birmingham University School of Medicine in 1991. Trained in cardiology and EP in the UK (Southampton University) and USA (Northwestern University and Children's Memorial Hospital, Chicago) Over 100 published manuscripts, 3 books and many book chapters. Active in clinical research, education and training

9 presentations from this speaker

The next level in CRT: new clinical evidence.

Event : HFA Discoveries 2020

  • Session : Device therapies in Heart failure continuum of care : time to treat!
  • Speaker : TR Betts (Oxford,GB)
  • Sponsored by Abbott

Left atrial appendage occluders - Indications

Event : EHRA 2019

  • Session : Burning questions in stroke management
  • Speaker : TR Betts (Oxford,GB)

From biventricular to multipoint pacing technology and LV only/or not?

Event : EHRA 2018

  • Session : Novel Approaches in Heart Failure management
  • Speaker : TR Betts (Oxford,GB)
  • Sponsored by Abbott

When should I consider transeptal left ventricular lead placement?

Event : EHRA 2018

  • Session : Individual solutions for challenging coronary vein anatomy
  • Speaker : TR Betts (Oxford,GB)

A multicentre experience of percutaneous left atrial appendage occlusion (LAAO) using different device technologies, with focus on long term outcome

Event : EHRA 2015

  • Session : Modern treatment of arrhythmias: data from clinical practice and registries
  • Speaker : TR Betts (Oxford,GB)

Case 1: "My patient suffered a hemorrhagic stroke and cannot take Warfarin."

Event : EHRA 2015

  • Session : Left atrial appendage closure: which of your AF patients benefit most?
  • Speaker : TR Betts (Oxford,GB)
  • Sponsored by Boston Scientific

Tissue contact monitoring with an electrical coupling index during radiofrequency energy pulmonary venous isolation - a prospective randomised control trial

Event : EHRA 2015

  • Session : How to improve procedural outcomes following atrial fibrillation ablation
  • Speaker : TR Betts (Oxford,GB)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are